An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Advertisement
Articles by Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
An overview of the REDUCE-IT trial of icosapent ethyl for the management of triglycerides and prevention of cardiovascular events.
The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.
The standard of care for managing high cholesterol levels.
The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.
Advertisement
Latest Updated Articles
Multidisciplinary Approaches to Reducing CVD RiskJanuary 14th 2022
- Strategies Used to Treat Hypercholesterolemia
January 14th 2022
Advertisement
Advertisement
Trending on Medical Economics
1
Why are claims being denied in 2026? 'Services not covered' now tops the list
2
Blue Cross and Blue Shield of Texas leaves Medicare Advantage as UnitedHealthcare splits with Florida health systems
3
Practices, patients, policy: Previewing the 2027 Medicare Physician Fee Schedule
4
Too small to be hacked? Why independent medical practices are prime targets for ransomware
5